are retreating in reaction to an adverse FDA verdict. FDA Goes With Panel Verdict In Rejecting Brinavess Correvio said it has received a complete response letter, or CRL, from the FDA for its NDA for …
More FDA Gives Thumbs Down To Correvio’s Atrial Fibrillation Drug Videos